State Issues Fresh Directive on ARVs for HIV/AIDS Patients
The Ministry of Health has issued a crucial directive: HIV/AIDS patients should only refill their antiretroviral (ARV) medication when their current supply is depleted.
This comes amidst concerns about potential shortages, but officials assure the public that current stocks are adequate.
Through the National AIDS & STI Control Programme (NASCOP), the Ministry emphasized that there’s no need for patients to panic or stockpile. “We have sufficient stocks of ARVs, both for prevention and treatment, at the ART sites,” they stated, aiming to dispel fears.
Patients are urged to adhere strictly to their prescribed schedules, visiting ART sites only when their medication is finished. This instruction is a direct response to reports of patients skipping doses or sharing medication due to anxiety over potential shortages.
The Ministry strongly advises against these practices. “ARVs should therefore be taken daily without skipping doses or sharing. Recipients of care are also advised not to refill ARVs before their due dates for fear of running out,” they reiterated.
The root of these concerns lies in the recent withdrawal of U.S. foreign aid, a significant source of funding for ARV medication, treatment, and related resources. This 90-day suspension has placed considerable strain on the healthcare system, particularly affecting ARV supplies.
In response, Health CS Deborah Barasa has sought an additional Ksh33.5 billion from the National Treasury. This funding is crucial for sustaining vital health programs, including HIV/AIDS treatment, malaria prevention, vaccines, and family planning.
Adding to the urgency, the United Nations Programme on HIV/AIDS (UNAIDS) has issued a stark warning.
Executive Director Winnie Byanyima cautioned that if U.S. aid is not restored promptly, the world could face a devastating resurgence of the HIV/AIDS pandemic, potentially leading to 6 million deaths within the next four years.
More News: Shock as NPSC Chairperson Candidate Komora Jilo Dies While Waiting for Interview
State Issues Fresh Directive on ARVs for HIV/AIDS Patients